NO984093D0 - FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposin-abledete peptider - Google Patents
FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposin-abledete peptiderInfo
- Publication number
- NO984093D0 NO984093D0 NO984093A NO984093A NO984093D0 NO 984093 D0 NO984093 D0 NO 984093D0 NO 984093 A NO984093 A NO 984093A NO 984093 A NO984093 A NO 984093A NO 984093 D0 NO984093 D0 NO 984093D0
- Authority
- NO
- Norway
- Prior art keywords
- prosaposin
- neuropathic pain
- methods
- derived peptides
- relieving neuropathic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/611,307 US6271196B1 (en) | 1996-03-05 | 1996-03-05 | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
PCT/US1997/004143 WO1997032895A1 (en) | 1996-03-05 | 1997-03-05 | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984093D0 true NO984093D0 (no) | 1998-09-04 |
NO984093L NO984093L (no) | 1998-11-04 |
Family
ID=24448513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984093A NO984093L (no) | 1996-03-05 | 1998-09-04 | FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposinavledede peptider |
Country Status (16)
Country | Link |
---|---|
US (2) | US6271196B1 (no) |
EP (1) | EP0929569B1 (no) |
JP (1) | JP4138006B2 (no) |
KR (1) | KR100507715B1 (no) |
AT (1) | ATE340187T1 (no) |
AU (1) | AU734566B2 (no) |
CA (1) | CA2248139C (no) |
CZ (1) | CZ297384B6 (no) |
DE (1) | DE69736712T2 (no) |
IL (1) | IL126082A0 (no) |
NO (1) | NO984093L (no) |
NZ (1) | NZ331757A (no) |
PL (1) | PL187917B1 (no) |
RU (2) | RU2266129C2 (no) |
SK (1) | SK122898A3 (no) |
WO (1) | WO1997032895A1 (no) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571787A (en) * | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
US6849602B1 (en) * | 1996-03-05 | 2005-02-01 | The Regents Of The University Of California | Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
CA2282827A1 (en) * | 1997-03-05 | 1998-09-11 | The Regents Of The University Of California | Method of alleviating neuropathic pain |
JP2001524944A (ja) * | 1997-03-05 | 2001-12-04 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 神経障害性疼痛の緩和方法 |
CA2284105A1 (en) * | 1997-03-24 | 1998-10-01 | John S. O'brien | Synthetic saposin c-derived neurotrophic peptides |
US6458357B1 (en) * | 1997-09-09 | 2002-10-01 | Myelos Corporation | Retro-inverso neurotrophic and analgesic peptides |
AU9774698A (en) * | 1997-09-09 | 1999-03-29 | Regents Of The University Of California, The | Inhibition of apoptotis using prosaposin receptor agonists |
BR9913490A (pt) * | 1998-08-28 | 2001-09-25 | Myelos Corp | Prosaposina cìclicos e seus usos |
US20020028783A1 (en) * | 1999-09-09 | 2002-03-07 | O'brien John S. | Method of stimulating prosaposin receptor activity |
USRE45976E1 (en) * | 1999-02-24 | 2016-04-19 | Tact Ip, Llc | Methods of inhibiting the action of TNF for neurological conditions by administering etanercept intrathecally |
CA2367766A1 (en) * | 1999-03-30 | 2000-10-05 | Myelos Corporation | Retro-inverso prosaposin-derived peptides and use thereof |
US7345019B1 (en) | 1999-04-13 | 2008-03-18 | The Kenneth S. Warren Institute, Inc. | Modulation of excitable tissue function by peripherally administered erythropoietin |
US7410941B1 (en) | 1999-04-13 | 2008-08-12 | The Kenneth S. Warren Institute, Inc. | Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin |
US7135461B1 (en) | 2000-06-16 | 2006-11-14 | Myelos Corporation | Retro-inverso peptides derived from interleukin-6 |
AU6540500A (en) * | 1999-06-16 | 2001-01-02 | Myelos Corporation | Retro-inverso peptides derived from interleukin-6 |
EP1183266A4 (en) * | 1999-06-16 | 2002-10-23 | Myelos Corp | INVERTED RETRO PEPTIDES DERIVED FROM LEUKEMIA INHBITION FACTOR |
US7109168B1 (en) | 2000-06-16 | 2006-09-19 | Myelos Corporation | Retro-inverso peptides derived from leukemia inhibitory factor |
WO2000077028A1 (en) * | 1999-06-16 | 2000-12-21 | Myelos Corporation | Retro-inverso peptides derived from interleukin-3 |
US20050074747A1 (en) * | 2000-09-08 | 2005-04-07 | Wadih Arap | Biopanning and rapid analysis of selective interactive ligands (brasil) |
US7420030B2 (en) | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
US7452964B2 (en) | 2001-09-07 | 2008-11-18 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
US20040170955A1 (en) * | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
US6531121B2 (en) | 2000-12-29 | 2003-03-11 | The Kenneth S. Warren Institute, Inc. | Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
US20060287240A1 (en) * | 2001-03-09 | 2006-12-21 | O'brien John S | Method of stimulating prosaposin receptor activity |
EP1418932A4 (en) * | 2001-07-18 | 2006-03-15 | Univ Texas | ANTI-ANGIOGENIC STATE IN MOUSE AND HUMAN BEINGS SUFFERING FROM CELL DEGENERATION OF THE RETINAL PHOTORECEPTOR |
US8507445B2 (en) * | 2001-09-07 | 2013-08-13 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US20040048243A1 (en) * | 2001-09-07 | 2004-03-11 | Wadih Arap | Methods and compositions for in vitro targeting |
US7671010B2 (en) * | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
WO2004016167A1 (en) * | 2002-08-16 | 2004-02-26 | The General Hospital Corporation | Non-invasive functional imaging of peripheral nervous system activation in humans and animals |
US7166691B2 (en) * | 2002-12-20 | 2007-01-23 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Saposin C and receptors as targets for treatment of benign and malignant disorders |
US20060275274A1 (en) * | 2003-03-26 | 2006-12-07 | Daria Onichtchouk | Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
CA2520125A1 (en) * | 2003-03-28 | 2004-10-14 | Acadia Pharmaceuticals Inc. | Muscarinic m1 receptor agonists for pain management |
CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
US7834147B2 (en) * | 2003-04-28 | 2010-11-16 | Childrens Hospital Medical Center | Saposin C-DOPS: a novel anti-tumor agent |
US9345745B2 (en) * | 2005-04-29 | 2016-05-24 | Bo Wang | Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides |
US7964585B2 (en) * | 2006-03-14 | 2011-06-21 | Case Western Reserve University | Composition and method of treating peripheral neuropathy |
WO2009094172A2 (en) | 2008-01-22 | 2009-07-30 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
RU2561582C2 (ru) * | 2010-11-19 | 2015-08-27 | Российская Федерация в лице Министерства промышленности и торговли Российской Федерации | Инъекционная лекарственная форма олигопептидного препарата для лечения рассеянного склероза и способ ее получения |
US9327012B2 (en) * | 2011-02-23 | 2016-05-03 | Sapporo Medical University | Composition for treating, improving, or preventing pain |
RU2669692C1 (ru) * | 2017-08-14 | 2018-10-15 | Павел Андреевич Канаев | Способ получения комплекса биологически активных пептидов обладающих нейротропной активностью |
US10682411B2 (en) | 2018-03-23 | 2020-06-16 | Bexion Pharmaceuticals Inc. | Saposin C pharmaceutical compositions and methods of treating cancer |
CN111936508A (zh) | 2018-03-29 | 2020-11-13 | 横向知识产权私人有限公司 | 环肽及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7180787A (en) | 1986-04-22 | 1987-10-29 | Salk Institute For Biological Studies, The | Fibroblast growth factor |
US5470582A (en) | 1992-02-07 | 1995-11-28 | Syntex (U.S.A.) Inc. | Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles |
US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
US5700909A (en) * | 1993-07-30 | 1997-12-23 | The Regents Of The University Of California | Prosaposin and cytokine-derived peptides |
CA2282827A1 (en) * | 1997-03-05 | 1998-09-11 | The Regents Of The University Of California | Method of alleviating neuropathic pain |
CA2284105A1 (en) * | 1997-03-24 | 1998-10-01 | John S. O'brien | Synthetic saposin c-derived neurotrophic peptides |
-
1996
- 1996-03-05 US US08/611,307 patent/US6271196B1/en not_active Expired - Fee Related
-
1997
- 1997-03-05 JP JP53205097A patent/JP4138006B2/ja not_active Expired - Fee Related
- 1997-03-05 AU AU23286/97A patent/AU734566B2/en not_active Ceased
- 1997-03-05 IL IL12608297A patent/IL126082A0/xx unknown
- 1997-03-05 RU RU2003131695/14A patent/RU2266129C2/ru not_active IP Right Cessation
- 1997-03-05 DE DE69736712T patent/DE69736712T2/de not_active Expired - Fee Related
- 1997-03-05 SK SK1228-98A patent/SK122898A3/sk unknown
- 1997-03-05 NZ NZ331757A patent/NZ331757A/en active IP Right Revival
- 1997-03-05 EP EP97916005A patent/EP0929569B1/en not_active Expired - Lifetime
- 1997-03-05 CA CA002248139A patent/CA2248139C/en not_active Expired - Fee Related
- 1997-03-05 KR KR1019980707151A patent/KR100507715B1/ko not_active IP Right Cessation
- 1997-03-05 AT AT97916005T patent/ATE340187T1/de not_active IP Right Cessation
- 1997-03-05 PL PL32870197A patent/PL187917B1/pl not_active IP Right Cessation
- 1997-03-05 RU RU98118091/04A patent/RU2223969C2/ru not_active IP Right Cessation
- 1997-03-05 CZ CZ0283998A patent/CZ297384B6/cs not_active IP Right Cessation
- 1997-03-05 WO PCT/US1997/004143 patent/WO1997032895A1/en active IP Right Grant
-
1998
- 1998-09-04 NO NO984093A patent/NO984093L/no not_active Application Discontinuation
-
1999
- 1999-01-15 US US09/231,159 patent/US6268347B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2248139A1 (en) | 1997-09-12 |
RU2003131695A (ru) | 2005-04-10 |
US6271196B1 (en) | 2001-08-07 |
DE69736712T2 (de) | 2007-09-13 |
NZ331757A (en) | 1999-10-28 |
AU734566B2 (en) | 2001-06-14 |
RU2266129C2 (ru) | 2005-12-20 |
US6268347B1 (en) | 2001-07-31 |
EP0929569B1 (en) | 2006-09-20 |
CZ297384B6 (cs) | 2006-11-15 |
DE69736712D1 (de) | 2006-11-02 |
IL126082A0 (en) | 1999-05-09 |
EP0929569A4 (en) | 2000-08-23 |
WO1997032895A1 (en) | 1997-09-12 |
JP2000506853A (ja) | 2000-06-06 |
ATE340187T1 (de) | 2006-10-15 |
AU2328697A (en) | 1997-09-22 |
RU2223969C2 (ru) | 2004-02-20 |
KR19990087686A (ko) | 1999-12-27 |
CZ283998A3 (cs) | 1999-05-12 |
SK122898A3 (en) | 2000-02-14 |
CA2248139C (en) | 2004-05-18 |
EP0929569A1 (en) | 1999-07-21 |
JP4138006B2 (ja) | 2008-08-20 |
KR100507715B1 (ko) | 2006-05-26 |
PL328701A1 (en) | 1999-02-15 |
NO984093L (no) | 1998-11-04 |
PL187917B1 (pl) | 2004-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO984093D0 (no) | FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposin-abledete peptider | |
AU7321598A (en) | Use of cholinesterase inhibitors to treat disorders of attention | |
EP0831832A4 (en) | METHODS FOR CONTROLLING INFECTIOUS DISEASES USING DICATIONIC BIS-BENZIMIDAZOLES | |
DK0867178T3 (da) | Non-allosteriske GABA A agonister til behandling af søvnforstyrrelser | |
AU9021298A (en) | Agmatine as a treatment for neuropathic pain | |
EP0813544A4 (no) | ||
EA199800866A1 (ru) | Способ снятия боли | |
EP1049479A4 (en) | ANALGESIC OBTAINED FROM SNAKE VENOM | |
AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
WO1999065475A3 (en) | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction | |
NO982582L (no) | Fremgangsmaate for behandling av smerte | |
EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
ATE270113T1 (de) | Zusammenstellungen zur verbesserten wundheilung | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
AU5434899A (en) | Cancer treatment | |
NO984198D0 (no) | Fremgangsmåte for behandling av aggresjon | |
IL126158A0 (en) | Method for treating substance abuse | |
NO984190L (no) | FremgangsmÕte for behandling av insomnia | |
AU4390597A (en) | Combination therapy for treatment of arthritic diseases | |
NO985325L (no) | Anvendelse av substituert azaspiran ved behandling av astma | |
UA32108A (uk) | Спосіб лікування хронічного тонзиліту | |
UA36341A (uk) | Спосіб лікування запальних процесів навколозубних тканин | |
UA8280A (uk) | Спосіб лікування псоріазу |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |